RE:RE:Go go gadget TLD1433silverT wrote: What do you mean by this "Merck might be interested in ensuring they maintain this market. Since they'll be making TLD1433 (via Sigma Aldrich) maybe they'll take a look. " , Don't we have an exclusive on TLD1433
TLT owns the full rights to the PDC/TLD1433
Sigma Aldrich hired by Theralase to manufacturd the PDC's
Shortlyafterwards, Merck bought Sigma Aldrich for 17B
So technically,,, Merck is manufacturing the compounds for TLT
Merck also has a lot of strategic plans for exploring emerging sciences/treatments/drugs/medical technologies.... so the suggestion is that they might take notice.
SAFC will develop the Standard Operating Procedures (“SOPs”) to manufacture initial quantities of each of Theralase’s four lead PDCs. Once Theralase selects the final lead PDC at the end of the fourth quarter 2014, SAFC will manufacture both a 100-gram pre-Good Manufacturing Practice (“pre-GMP”) batch and finally a 500-gram GMP batch of the PDC. This final 500-gram batch is intended to be suitable for final sterilization and packaging into individual patient doses for safety and efficacy evaluation through a Health Canada / FDA Phase I/IIa clinical trial